Release Date: 03/10/16 12:01 Summary: Valentia Investment Update-EVM.AX Price Sensitive: No Download Document 288.5KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%